AI assistant
Sending…
MACROGENICS INC — Director's Dealing 2025
Dec 10, 2025
34129_dirs_2025-12-10_85e3d618-fdaf-4fff-b708-c61316da48cf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2025-12-08
Reporting Person: Smith Beth Ann (VP, Controller & Treasurer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-12-08 | Employee Stock Option (right to buy) | $1.33 | A | 25000 | Acquired | 2035-12-08 | Common Stock (25000) | Direct |
Footnotes
F1: 25% of the options will vest and become exercisable one year from the grant date and the remaining 75% will vest in 12 substantially equal quarterly installments thereafter
More from MACROGENICS INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18